Becton Dickinson
Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BDX
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional.
BDX Key Statistics
Stock Snapshot
The current Becton Dickinson(BDX) stock price is $177.84, with a market capitalization of 50.99B. The stock trades at a price-to-earnings (P/E) ratio of 30.56 and offers a dividend yield of 2.3%.
On 2025-11-09, Becton Dickinson(BDX) stock moved within a range of $174.72 to $179.05. With shares now at $177.84, the stock is trading +1.8% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 2.81M, compared to an average daily volume of 3.18M.
The stock's 52-week range extends from a low of $162.29 to a high of $251.99.
The stock's 52-week range extends from a low of $162.29 to a high of $251.99.
BDX News
Becton, Dickinson and Company ( ) will increase its dividend on the 31st of December to $1.05, which is 1.0% higher than last year's payment from the same perio...
New insider activity at Becton Dickinson ( (BDX) ) has taken place on November 7, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can hel...
RBC Capital analyst Shagun Singh lowered the firm’s price target on Becton Dickinson (BDX) to $202 from $211 and keeps a Sector Perform rating on the shares. Th...
Analyst ratings
60%
of 15 ratingsMore BDX News
Becton, Dickinson and Company announced quarterly and full-year earnings results, reporting fourth quarter sales of US$5.89 billion and net income of US$493 mil...
Becton, Dickinson and Co ((BDX)) has held its Q4 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF...
Analyst Josh Jennings from TD Cowen maintained a Hold rating on Becton Dickinson and keeping the price target at $183.00. Meet Your ETF AI Analyst Discover how...
Becton Dickinson and Co (NYSE:BDX) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92. • BDX is in a challenging position. Foll...
Reports Q4 revenue $5.89B, consensus $5.91B. “Our resilient business model and commitment to commercial and operational execution enabled us to deliver 3.9% org...
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) initiated its adjus...
(RTTNews) - Becton, Dickinson and Company (BDX) will host a conference call at 8:00 AM ET on November 6, 2025, to discuss Q4 25 earnings results. To access the...